+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons



Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons



Chest 127(4): 1296-1303



Background: Recently, a short-course treatment using 60 daily doses of rifampin and pyrazinamide was recommended for latent tuberculosis (TB) infection (LTBI).Study objectives: To determine the acceptability, tolerability, and completion of treatment.Design: Observational cohort study.Setting: Five county jails and TB outreach clinics for homeless populations in three cities.Patients: Study staff enrolled 1,211 patients (844 inmates and 367 homeless persons).Interventions: Sites used 60 daily doses of rifampin and pyrazinamide, an approved treatment regimen for LTBI.Measurements: Types and frequency of drug-related adverse events and outcomes of treatment.Results: Prior to treatment, 25 of 1, 178 patients (2.1%) had a serum aminotransferase measurement at least 2.5 times the upper limit of normal. Patients who reported excess alcohol use in the past 12 months were more likely than other patients to have an elevated pretreatment serum aminotransferase level (odds ratio, 2.1; 95% confidence interval, 1.1 to 6.1; p = 0.03). Treatment was stopped in 66 of 162 patients (13.4%) who had a drug-related adverse event. Among 715 patients who had serum aminotransferase measured during treatment, 43 patients (6.0%) had an elevation > 5 times the upper limits of normal, including one patient who died of liver failure attributed to treatment. In multivariate analyses, increasing age, an abnormal baseline aspartate aminotransferase level, and unemployment within the past 24 months were independent risk factors for hepatotoxicity. Completion rates were similar in jail inmates (47.5%) and homeless persons (43.6%).Conclusions: This study detected the first treatment-associated fatality with the rifampin and pyrazinamide regimen, prompting surveillance that detected unacceptable levels of hepatotoxicity and retraction of recommendations for its routine use. Completion rates for LTBI treatment using a short-course regimen exceeds historical rates using isoniazid. Efforts to identify an effective short-course treatment for LTBI should be given a high priority.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011734153

Download citation: RISBibTeXText

PMID: 15821208


Related references

Adverse Events and Treatment Completion for Latent Tuberculosis in Jail Inmates and Homeless Persons. Yearbook of Pulmonary Disease 2006: 310-312, 2006

Adverse Events and Treatment Completion for Latent Tuberculosis in Jail Inmates and Homeless Persons. Chest 127(4): 1296-1303, 2005

Completion Rates, Adverse Effects, and Costs of a 3-Month and 9-Month Treatment Regimen for Latent Tuberculosis Infection in California Inmates, 2011-2014. Public Health Reports 134(1_Suppl): 71s-79s, 2019

Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates. Chest 119(3): 833-837, 2001

Latent variable assessment of outcomes in a nurse-managed intervention to increase latent tuberculosis treatment completion in homeless adults. Health Psychology 26(1): 68-76, 2007

Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail. Open Forum Infectious Diseases 3(1): Ofv220, 2016

Isoniazid vs. rifampin for latent tuberculosis infection in jail inmates: toxicity and adherence. Journal of Correctional Health Care 18(2): 131-142, 2012

In-jail education improves completion of tuberculosis treatment after release from jail. Evidence-Based Healthcare 6(4): 167-168, 2002

Adverse events associated with treatment of latent tuberculosis in the general population. Cmaj 183(3): E173-E179, 2011

Rapid rehousing of formerly homeless jail and prison inmates. Housing Care and Support 20(4): 137-151, 2017

Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis. Cmaj 167(2): 131-136, 2002

A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts. Clinical Infectious Diseases 49(3): 424-427, 2009

Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB. Thorax 65(7): 582-587, 2010

The Jail Inreach Project: linking homeless inmates who have mental illness with community health services. Psychiatric Services 62(2): 120-122, 2011

Traumatic life events and suicide risk among jail inmates: the influence of types of events, time period and significant others. Journal of Traumatic Stress 15(1): 9, 2002